Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05227027 · ClinicalTrials.gov registry record · NA
Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation
A NA study of Cigarette Smoking-Related Carcinoma, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT05227027: Completed NA study of Cigarette Smoking-Related Carcinoma, sponsored by University of California, San Francisco.
NCT05227027 is a NA study of Cigarette Smoking-Related Carcinoma that has completed, run by University of California, San Francisco. The registered enrollment target is 500 participants, above the 443-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05227027, a NA study of Cigarette Smoking-Related Carcinoma, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the effects of a video game embedded in a commercially available mobile application (app) for smoking cessation. Smokers are increasingly turning to mobile health apps for assistance with quitting smoking, and there is a critical need for strategies to engage app users to increase retention and efficacy. Video games are designed to increase users' motivation and engagement, which in turn may increase their exposure and adherence to a smoking cessation program. The hypothesis is that the game increases engagement, retention, and smoking abstinence rates compared with a core version of the app without the game. A two-arm individually randomized pilot trial of 500 adult smokers will test this hypothesis, comparing outcomes for participants randomized to receive the core app plus embedded game with participants randomized to receive the core app only. Primary outcomes relate to user engagement with the app. Secondary outcomes relate to user engagement, efficacy (smoking abstinence), and user satisfaction.
Primary Outcome
Number of times the app was opened; passively collected by the app and averaged in analysis to calculate mean number of app opens by study group over the study period. A new session is defined as use of the app after at least 30 minutes of inactivity.
Conditions Studied
Interventions
- BEHAVIORAL Game Module
- BEHAVIORAL Smoke Free smartphone application
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-02-09 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
What the finished NCT05227027 record still lists
NCT05227027 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 443-participant average among 21 other Cigarette Smoking-Related Carcinoma trials with a reported enrollment target (13% higher).
The record links to 1 condition, with Cigarette Smoking-Related Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Game Module is the first listed.
NCT05227027 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05227027 about?
NCT05227027 is a clinical study titled "Pilot Trial of a Game Embedded in a Smartphone App for Smoking Cessation". This study evaluates the effects of a video game embedded in a commercially available mobile application (app) for smoking cessation. Smokers are increasingly turning to mobile health apps for assistance with quitting smoking, and there is a critical need for strategies to engage app users to increa...
What is the current status of trial NCT05227027?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2022-02-09. Estimated completion is 2022-05-31.
What conditions does trial NCT05227027 study?
This clinical trial studies the following conditions: Cigarette Smoking-Related Carcinoma.
What interventions are being tested in trial NCT05227027?
The interventions under investigation include: Game Module (BEHAVIORAL), Smoke Free smartphone application (BEHAVIORAL).
Who is sponsoring clinical trial NCT05227027?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05227027 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking-Related Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05227027's enrollment target sits among peer trials
500 7th of 21 higher than 15 of 21 other Cigarette Smoking-Related Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial
RECRUITING · NA
-
CONNECTing to LungCare
RECRUITING · NA
-
Smoking Cessation Intervention Development for Homeless Youth
RECRUITING · NA
-
Studying Flavors and Cooling Agents in Oral Nicotine Pouches to Understand User Preferences
RECRUITING · NA
-
Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia
RECRUITING · NA
-
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI